JP2016539129A5 - - Google Patents

Download PDF

Info

Publication number
JP2016539129A5
JP2016539129A5 JP2016533609A JP2016533609A JP2016539129A5 JP 2016539129 A5 JP2016539129 A5 JP 2016539129A5 JP 2016533609 A JP2016533609 A JP 2016533609A JP 2016533609 A JP2016533609 A JP 2016533609A JP 2016539129 A5 JP2016539129 A5 JP 2016539129A5
Authority
JP
Japan
Prior art keywords
cancer
composition
cell
melanoma
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016533609A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016539129A (ja
JP6560215B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/066543 external-priority patent/WO2015077411A1/en
Publication of JP2016539129A publication Critical patent/JP2016539129A/ja
Publication of JP2016539129A5 publication Critical patent/JP2016539129A5/ja
Application granted granted Critical
Publication of JP6560215B2 publication Critical patent/JP6560215B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016533609A 2013-11-20 2014-11-20 Mhc−iの発現を増加させるためのクルクフェノール化合物 Expired - Fee Related JP6560215B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361906817P 2013-11-20 2013-11-20
US61/906,817 2013-11-20
PCT/US2014/066543 WO2015077411A1 (en) 2013-11-20 2014-11-20 Curcuphenol compounds for increasing mhc-i expression

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019132434A Division JP2019196380A (ja) 2013-11-20 2019-07-18 Mhc−iの発現を増加させるためのクルクフェノール化合物

Publications (3)

Publication Number Publication Date
JP2016539129A JP2016539129A (ja) 2016-12-15
JP2016539129A5 true JP2016539129A5 (https=) 2017-12-28
JP6560215B2 JP6560215B2 (ja) 2019-08-14

Family

ID=52117996

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016533609A Expired - Fee Related JP6560215B2 (ja) 2013-11-20 2014-11-20 Mhc−iの発現を増加させるためのクルクフェノール化合物
JP2019132434A Withdrawn JP2019196380A (ja) 2013-11-20 2019-07-18 Mhc−iの発現を増加させるためのクルクフェノール化合物
JP2021064761A Expired - Fee Related JP7071570B2 (ja) 2013-11-20 2021-04-06 Mhc-iの発現を増加させるためのクルクフェノール化合物
JP2022076869A Pending JP2022093724A (ja) 2013-11-20 2022-05-09 Mhc-iの発現を増加させるためのクルクフェノール化合物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2019132434A Withdrawn JP2019196380A (ja) 2013-11-20 2019-07-18 Mhc−iの発現を増加させるためのクルクフェノール化合物
JP2021064761A Expired - Fee Related JP7071570B2 (ja) 2013-11-20 2021-04-06 Mhc-iの発現を増加させるためのクルクフェノール化合物
JP2022076869A Pending JP2022093724A (ja) 2013-11-20 2022-05-09 Mhc-iの発現を増加させるためのクルクフェノール化合物

Country Status (10)

Country Link
US (4) US20150147314A1 (https=)
EP (2) EP3071192B1 (https=)
JP (4) JP6560215B2 (https=)
CN (1) CN106456572A (https=)
CA (1) CA2930156C (https=)
DK (1) DK3071192T3 (https=)
ES (1) ES2775577T3 (https=)
HU (1) HUE049301T2 (https=)
PL (1) PL3071192T3 (https=)
WO (1) WO2015077411A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2930156C (en) 2013-11-20 2023-11-07 Biommune Technologies Inc. Curcuphenol compounds for increasing mhc-i expression
EP3324967A4 (en) * 2015-07-22 2019-03-20 Prilenia Therapeutics Development Ltd. PRIDOPIDINE-BASED FORMULATIONS AND USE OF THE SAME
JP7520013B2 (ja) * 2018-12-17 2024-07-22 イントラ-セルラー・セラピーズ・インコーポレイテッド 置換複素環縮合γ-カルボリンの合成
WO2020154811A1 (en) 2019-01-31 2020-08-06 Cava Healthcare Inc. Compounds for increasing mhc-i expression and modulating histone deacetylase activity
TW202214245A (zh) * 2020-08-10 2022-04-16 國立彰化師範大學 雙非癌藥物用於製備治療癌症之醫藥組合物的用途
WO2022125339A2 (en) * 2020-12-07 2022-06-16 The Trustees Of Indiana University Methods to sensitize cancer cells to immune attack using atractylenolide i

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6261939A (ja) * 1985-09-10 1987-03-18 Yamanouchi Pharmaceut Co Ltd クルクフエノ−ル誘導体及びこれを含有する医薬
KR100439425B1 (ko) * 2001-03-22 2004-07-05 (주)바이오케어 잔토리졸을 포함하는 조성물 및 그 용도
KR100571159B1 (ko) * 2003-06-24 2006-04-18 박광균 항암제로 유발되는 독성의 억제제 및 이를 함유하는항암제 조성물
CA2688570A1 (en) * 2007-05-31 2008-12-04 F.P.L. Pharma Inc. Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof
CA2930156C (en) 2013-11-20 2023-11-07 Biommune Technologies Inc. Curcuphenol compounds for increasing mhc-i expression

Similar Documents

Publication Publication Date Title
JP2016539129A5 (https=)
US20230241244A1 (en) Nano-enabled immunotherapy in cancer
AU2020367786A1 (en) Nano-enabled immunotherapy in cancer
JP7071570B2 (ja) Mhc-iの発現を増加させるためのクルクフェノール化合物
US20200308286A1 (en) Methods, compositions, and kits for treatment of cancer
US20210079112A1 (en) Combination of near infrared photoimmunotherapy targeting cancer cells and host-immune activation
CA3149537A1 (en) Biomarkers for determining the efficacy of immune checkpoint inhibitors
JP2024513505A (ja) 腫瘍を治療するための組成物及び方法
JP7772847B2 (ja) 抗がん剤の送達のためのステレオコンプレックス
US20220249682A1 (en) Polymeric drug delivery conjugates and methods of making and using thereof
WO2021206160A1 (ja) 抗体薬物複合体
US20240101685A1 (en) Near infrared photoimmunotherapy (nir-pit) combination therapy to treat cancer
JP2020132638A5 (https=)
WO2021206158A1 (ja) がん治療方法
WO2021205631A1 (ja) Sting作動化合物
WO2023196984A2 (en) Multifunctional nanoparticles and uses in managing cancer and cardiovascular diseases
HK40078343B (zh) 用於递送抗癌剂的立体复合物